- EN
2010 priorities and budget
The EMCDDA’s 2010 work programme is the first to fall under the agency’s new three-year strategy and work plan for 2010–12. This three-year strategy seeks to consolidate and deepen the analysis of core data held at the EMCDDA and develops a number of new areas of strategic importance. It also reflects the obligations of the agency’s mission statement and is sensitive to the needs of the EU drugs strategy and action plan (2009–12).
The purpose of the 2010 work programme, adopted by the Management Board in December 2009, is to map the activities to be undertaken this year and to establish the methods needed to attain goals set for 2012. It is organised around a number of core business areas, including monitoring the drug situation and responses, monitoring and evaluating policies, and tracking new drugs and trends.
Greater emphasis will be placed in 2010 on data quality, with quality-assurance measures and routines planned to guarantee accurate statistical and data analyses. And priority is given to the cross analysis of key indicator data to gain better insight into issues such as polydrug use and morbidity. Also emphasised is the need to lay groundwork for European level guidelines, frameworks and standards, as required by the EU drugs action plan.
In terms of methodological improvements, the EMCDDA aims with this programme to: further develop the five key epidemiological indicators; fine-tune data collection in the area of public expenditure; and increase its focus on instruments and procedures for monitoring responses. It is also endeavouring to become more sensitive to detecting and exchanging information on emerging trends and to improve the monitoring of drug supply and supply reduction activities. New products in the pipeline for 2010 include a scientific monograph on harm reduction practice and EMCDDA–Europol joint publications on cocaine and amphetamine.
The EMCDDA will continue to work in networks and to strengthen its collaboration with partners both in Europe and beyond. In line with its international cooperation strategy, it will provide technical assistance to candidate and potential candidate countries to the EU and to partner countries within the European Neighbourhood Policy. The Management Board adopted a total budget of EUR 16 000 000 for 2010.
Monika Blum
In this issue...
- 2010 priorities and budget
- Management Board: changes at the helm
- EMCDDA and Europol step up information collection on mephedrone
- Guidelines for collecting data on retail drug prices
- Hepatitis C prevalence as a possible indicator of injection-related HIV risk
- Health and prisons in Europe
- Best practice portal: upcoming developments
- European drug prevention quality standards
- Role of Community agencies in EU enlargement process reinforced
- EMCDDA signs accord with Ukrainian Ministry of Health
- New Czech penal code enters into force
- EMCDDA and Canadian partners outline areas for cooperation
- Implementation of the EMCDDA’s five key epidemiological indicators
- Reitox development strategy 2010–15
- Scientific Committee underlines importance of scientific publishing
Drugnet Europe is also available in downloadable PDF format, for printing or offline browsing.
Drugnet Europe is the EMCDDA's newsletter launched in September 1996. The newsletter provides regular and succint information on the Centre's projects and activities to a broad readership.
Page last updated: Thursday, 11 March 2010